TKO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Given the mixed signals from technical analysis, options data, and analyst ratings, combined with the user's preference for long-term investment and beginner-level knowledge, TKO is not a strong buy at the moment. The stock's valuation appears to be priced in, and there are no immediate positive catalysts or trading signals to justify an entry point. Holding off for now is recommended.
The MACD histogram is negative (-1.151) and contracting, suggesting bearish momentum. RSI is neutral at 36.293, and moving averages are converging, indicating no clear trend. The stock is trading near its support level (S1: 188.998), with resistance at 195.503. Overall, technical indicators do not provide a strong buy signal.
Hedge funds are significantly increasing their positions, with a 966.71% increase in buying over the last quarter. Analysts have raised price targets, with some projecting up to $260, citing strong growth prospects and recurring revenue streams.
Insiders are selling heavily, with a 345.87% increase in selling activity over the last month. Analysts have downgraded the stock due to valuation concerns, and some believe the stock's upside is already priced in. Additionally, financials show a significant YoY revenue drop (-27.31%), and there are no recent news or event-driven catalysts.
In 2025/Q3, revenue dropped significantly by -27.31% YoY to $1.12B. However, net income increased by 77.23% YoY to $41M, and EPS grew by 67.86% YoY to 0.47. Gross margin improved substantially to 49.21%, up 83% YoY. While profitability metrics are improving, the revenue decline is a concern.
Analyst sentiment is mixed. While several analysts have raised price targets (e.g., Roth Capital to $260, Pivotal Research to $250), others have downgraded the stock due to valuation concerns (e.g., Wolfe Research to Peer Perform, Seaport Research to Neutral). The consensus suggests that the stock's valuation may already reflect its growth potential.
